LFWD
Price
$5.85
Change
-$0.11 (-1.85%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
19.6M
46 days until earnings call
Intraday BUY SELL Signals
MBOT
Price
$1.16
Change
-$0.05 (-4.17%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
83.96M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LFWD vs MBOT

LFWD vs MBOT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LFWD vs. MBOT commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFWD is a StrongBuy and MBOT is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
LFWD vs MBOT: Fundamental Ratings
LFWD
MBOT
OUTLOOK RATING
1..100
5869
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
7589
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LFWD's Valuation (25) in the Medical Specialties industry is in the same range as MBOT (35) in the Biotechnology industry. This means that LFWD’s stock grew similarly to MBOT’s over the last 12 months.

LFWD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MBOT (100) in the Biotechnology industry. This means that LFWD’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's SMR Rating (97) in the Biotechnology industry is in the same range as LFWD (100) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to LFWD’s over the last 12 months.

LFWD's Price Growth Rating (75) in the Medical Specialties industry is in the same range as MBOT (89) in the Biotechnology industry. This means that LFWD’s stock grew similarly to MBOT’s over the last 12 months.

LFWD's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as MBOT (100) in the Biotechnology industry. This means that LFWD’s stock grew similarly to MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFWDMBOT
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 15 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (LFWD: $5.96 vs. MBOT: $1.20)
Brand notoriety: LFWD and MBOT are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LFWD: 251% vs. MBOT: 114%
Market capitalization -- LFWD: $19.6M vs. MBOT: $83.96M
LFWD [@Medical/Nursing Services] is valued at $19.6M. MBOT’s [@Medical/Nursing Services] market capitalization is $83.96M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFWD’s FA Score shows that 1 FA rating(s) are green while MBOT’s FA Score has 0 green FA rating(s).

  • LFWD’s FA Score: 1 green, 4 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, both LFWD and MBOT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFWD’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 3 bullish TA indicator(s).

  • LFWD’s TA Score: 4 bullish, 5 bearish.
  • MBOT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both LFWD and MBOT are a bad buy in the short-term.

Price Growth

LFWD (@Medical/Nursing Services) experienced а -14.49% price change this week, while MBOT (@Medical/Nursing Services) price change was -8.40% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was -6.04%, and the average quarterly price growth was -2.68%.

Reported Earning Dates

LFWD is expected to report earnings on Nov 17, 2026.

MBOT is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
LFWD
Daily Signal:
Gain/Loss:
MBOT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XJH49.240.46
+0.95%
iShares ESG Select Screened S&P Mid-Cap ETF (XJH)
USIN46.970.17
+0.36%
WisdomTree 7-10 Year Laddered Treasury Fund (USIN)
ZMUN49.460.10
+0.20%
F/m Ultrashort Tax-Free Municipal ETF (ZMUN)
ITDD38.280.03
+0.08%
iShares LifePath Target Date 2040 ETF (ITDD)
IBTI21.93N/A
N/A
iShares iBonds Dec 2028 Term Treasury ETF

LFWD and

Correlation & Price change

A.I.dvisor tells us that LFWD and MBOT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFWD and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFWD
1D Price
Change %
LFWD100%
-9.97%
MBOT - LFWD
32%
Poorly correlated
N/A
ALGN - LFWD
27%
Poorly correlated
-0.00%
SENS - LFWD
25%
Poorly correlated
-2.06%
UFPT - LFWD
25%
Poorly correlated
-0.62%
LUCD - LFWD
25%
Poorly correlated
-15.47%
More

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with AGPU. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then AGPU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
N/A
AGPU - MBOT
37%
Loosely correlated
+0.44%
QSI - MBOT
35%
Loosely correlated
+33.64%
AIMD - MBOT
32%
Poorly correlated
+2.36%
LFWD - MBOT
31%
Poorly correlated
-9.97%
CODX - MBOT
31%
Poorly correlated
+0.93%
More